Screener
Amneal Pharmaceuticals, Inc. AMRX Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Class B common stock, $0.01 par value, 300,000 shares authorized at both June 30, 2026 and December 31, 2025; none issued at both June 30, 2026 and December 31, 2025 | — | — |
| Additional paid-in capital | 545,584 | 571,794 |
| Stockholders’ accumulated deficit | (415,087) | (535,005) |
| Accumulated other comprehensive loss | (100,666) | (110,729) |
| Total Amneal Pharmaceuticals, Inc. stockholders’ equity (deficiency) | 33,024 | (70,794) |
| Non-controlling interests | — | (535) |
| Total stockholders’ equity (deficiency) | 33,024 | (71,329) |
| Total liabilities and stockholders’ equity (deficiency) | $3,776,348 | $3,678,280 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s non-controlling interests?
- Amneal Pharmaceuticals, Inc. (AMRX) reported non-controlling interests of $0 in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s non-controlling interests changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s non-controlling interests increased by 100.0% year-over-year, from -$415K to $0.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s non-controlling interests?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s non-controlling interests has grown at a -58.1% compound annual growth rate (CAGR), from $41.66M to -$535K.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.
Ask your AI about Amneal Pharmaceuticals, Inc.'s non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude